NL-OMON20648尚未招募不适用
Intraperitoneal Natural Killer cell therapie against recurrent ovarian cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- Radboudumc
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients suffering from their second recurrence of ovarian, fallopian tube or primary peritoneal cancer, with an elevated serum level of CA-125 on two successive time points with 28 days in between, reaching a value of more than 2 times nadir and above 35 U/ml without gastrointestinal symptoms.
- •Able to undergo laparoscopic IP port placement and IP treatment administration
排除标准
- •Patients on immunosuppressive drugs
- •Patients with active infections (viral, bacterial or fungal) that requires specific therapy. Acute anti-infectious therapy must have been completed within 14 days prior to study treatment
研究者
相似试验
招募中
Unknown
Cell therapy using natural killer cells pretreatment with Anti-NKG2A in patients with hepatocellular carcinomaIRCT20140818018842N41Tehran University of Medical Sciences3
招募中
1 期
atural Killer cell in acute myeloid leukemiaAcute myeloblastic leukemiaacute myeloid leukemia.C92.0IRCT20140818018842N35Tehran University of Medical Sciences10
进行中（未招募）
不适用
Infusion of Cytokine Induced Killer (CIK) cells in patients relapsing after allogeneic stem cell transplantation - CIKEUCTR2008-006862-27-ITAZIENDA OSPEDALIERA OSPEDALI RIUNITI DI BERGAMO (A.O. DI RILIEVO NAZIONALE)
招募中
1 期
Combinational Cell Therapy using Natural Killer Cells and Erbitux in Patients with Advanced Gastric AdenocarcinomaGastric Adenocarcinoma.C16. 9 Malignant neoplasm: Stomach, unspecifiedC16. 9IRCT20140818018842N36Tehran University of Medical Sciences3
进行中（未招募）
1 期
Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with Non-Small Cell Lung Cancer (NSCLC) after radiochemotherapy (RCT)EUCTR2008-002130-30-DETechnische Universität München Fakultät für Medizin90